human | Q5 |
P6178 | Dimensions author ID | 0621745360.53 |
P269 | IdRef ID | 120182068 |
P244 | Library of Congress authority ID | no2004095008 |
P2798 | Loop ID | 320262 |
P8189 | National Library of Israel J9U ID | 987007291269405171 |
P496 | ORCID iD | 0000-0002-4503-5739 |
0000-0003-4968-8291 | ||
P1153 | Scopus author ID | 36148493700 |
7006219133 | ||
P214 | VIAF ID | 100144782960135772099 |
P10832 | WorldCat Entities ID | E39PBJfX73qYjc7PGtFDtXK68C |
P108 | employer | Severo Ochoa Molecular Biology Center | Q20013983 |
P735 | given name | Francisco | Q7201446 |
Francisco | Q7201446 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q39720603 | A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge |
Q40508967 | A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. |
Q56980102 | A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine |
Q92636588 | A Single Dose of Dendrimer B2T Peptide Vaccine Partially Protects Pigs against Foot-and-Mouth Disease Virus Infection |
Q40275103 | A T-cell epitope on NS3 non-structural protein enhances the B and T cell responses elicited by dendrimeric constructions against CSFV in domestic pigs |
Q93022563 | A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease |
Q40054641 | A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus. |
Q44911786 | A computer program for the design of PCR primers for diagnosis of highly variable genomes. |
Q45753381 | A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. |
Q40749325 | A recombinant DNA vaccine protects mice deficient in the alpha/beta interferon receptor against lethal challenge with Usutu virus |
Q39606030 | A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. |
Q39755293 | A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition |
Q39617181 | A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance |
Q38017490 | Acid-dependent viral entry. |
Q72088196 | Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice |
Q79083577 | Allergen-dependent CD14 modulation and apoptosis in monocytes from allergic patients |
Q38329668 | An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage. |
Q44046199 | Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins |
Q45494351 | Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus |
Q45789599 | Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. |
Q99348100 | Association of Porcine Swine Leukocyte Antigen (SLA) Haplotypes with B- and T-Cell Immune Response to Foot-and-Mouth Disease Virus (FMDV) Peptides |
Q56980058 | Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge |
Q27488277 | Attenuated Foot-and-Mouth Disease Virus RNA Carrying a Deletion in the 3' Noncoding Region Can Elicit Immunity in Swine |
Q37426707 | B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines |
Q39707385 | Cell density-dependent expression of viral antigens during persistence of foot-and-mouth disease virus in cell culture |
Q61881303 | Characterization of Calcineurin in Human Neutrophils |
Q39120462 | Characterization of a nuclear localization signal in the foot-and-mouth disease virus polymerase |
Q40286624 | Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. |
Q57469924 | Contribution of a Multifunctional Polymerase Region of Foot-and-Mouth Disease Virus to Lethal Mutagenesis |
Q42499587 | Cyclosporin A antagonizes phenylephrine, oxytocin and angiotensin effects on glucose metabolism in rat thymus lymphocytes. |
Q45369151 | DNA immunization of pigs with foot-and-mouth disease virus minigenes: from partial protection to disease exacerbation |
Q51936045 | DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. |
Q56902233 | DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses |
Q42254882 | Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice |
Q41806887 | Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle. |
Q39767380 | Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response |
Q40633098 | Design and construction of African swine fever virus chimeras incorporating foreign viral epitopes. |
Q97687575 | Designing Functionally Versatile, Highly Immunogenic Peptide-Based Multiepitopic Vaccines against Foot-and-Mouth Disease Virus |
Q61881053 | Different signaling pathways inhibit DNA methylation activity and up-regulate IFN- in human lymphocytes |
Q40290305 | Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells |
Q42552951 | Discriminating foot-and-mouth disease virus-infected and vaccinated animals by use of beta-galactosidase allosteric biosensors. |
Q61881388 | Effect of thimerosal and other sulfhydryl reagents on calcium permeability in thymus lymphocytes |
Q43570354 | Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. |
Q39763867 | Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. |
Q54545817 | Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors. |
Q42238447 | Enhancement of Antigen-specific functional responses by neutrophils from allergic patients. |
Q39480511 | Equine Rhinitis A Virus Mutants with Altered Acid Resistance Unveil a Key Role of VP3 and Intrasubunit Interactions in the Control of the pH Stability of the Aphthovirus Capsid. |
Q56980168 | Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns |
Q39699119 | Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo |
Q35044856 | Evolution of foot-and-mouth disease virus |
Q31075115 | Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity |
Q80558353 | Expression of the transcription factor NFAT2 in human neutrophils: IgE-dependent, Ca2+- and calcineurin-mediated NFAT2 activation |
Q38769909 | First Complete Coding Sequence of a Spanish Isolate of Swine Vesicular Disease Virus |
Q34940508 | Foot-and-mouth disease virus |
Q45362149 | Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells. |
Q34935334 | Foot-and-mouth disease virus: biology and prospects for disease control |
Q40865295 | Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide |
Q45780865 | Gene expression profiles in the cerebellum of transgenic mice over expressing the human FMR1 gene with CGG repeats in the normal range |
Q41714045 | Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine |
Q56979958 | Genomic and antigenic characterization of viruses from the 1993 Italian foot-and-mouth disease outbreak |
Q68197659 | Glucocorticoids inhibit fructose 2,6-bisphosphate synthesis in rat thymocytes. Opposite effect of cycloheximide |
Q40128599 | Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host |
Q61880928 | Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils |
Q44122946 | Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions |
Q69886166 | Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat |
Q36617464 | Host sphingomyelin increases West Nile virus infection in vivo |
Q44922465 | Human neutrophils synthesize IL-8 in an IgE-mediated activation. |
Q39602247 | Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. |
Q74080016 | IgE-dependent release of myeloperoxidase by neutrophils from allergic patients |
Q56980045 | IgE-mediated downregulation of L-selectin (CD62L) on lymphocytes from asthmatic patients |
Q55031351 | Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle. |
Q45647095 | Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. |
Q40321336 | Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV. |
Q42046690 | Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site |
Q93047536 | Inhibition of Porcine Viruses by Different Cell-Targeted Antiviral Drugs |
Q39813573 | Inhibition of enveloped virus infection of cultured cells by valproic acid |
Q38799906 | Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid |
Q39144060 | Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. |
Q73440243 | Inhibitory effect of albumin-derived advanced glycosylation products on PMA-induced superoxide anion production by rat macrophages |
Q56979762 | Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus |
Q45362221 | Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection. |
Q51818186 | Intermediate alleles at the FRAXA and FRAXE loci in Parkinson's disease. |
Q39882487 | Internalization of swine vesicular disease virus into cultured cells: a comparative study with foot-and-mouth disease virus. |
Q33805171 | Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. |
Q98906652 | MDA5 cleavage by the Leader protease of foot-and-mouth disease virus reveals its pleiotropic effect against the host antiviral response |
Q40727059 | Macrophage inducible nitric oxide synthase gene expression is blocked by a benzothiophene derivative with anti-HIV properties. |
Q38951275 | Membrane topology and cellular dynamics of foot-and-mouth disease virus 3A protein |
Q28577262 | Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production |
Q38824741 | Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication |
Q54607397 | Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils. |
Q39300545 | Modulation of foot-and-mouth disease virus pH threshold for uncoating correlates with differential sensitivity to inhibition of cellular Rab GTPases and decreases infectivity in vivo. |
Q61881429 | Modulation of phorbol ester-induced respiratory burst by vanadate, genistein, and phenylarsine oxide in mouse macrophages |
Q40632247 | Molecular epidemiology of classical swine fever in Cuba. |
Q41027592 | Multifunctionality of a picornavirus polymerase domain: nuclear localization signal and nucleotide recognition |
Q39316035 | Mutations that hamper dimerization of foot-and-mouth disease virus 3A protein are detrimental for infectivity |
Q40923514 | NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. |
Q89518630 | Negatively charged amino acids at the foot-and-mouth disease virus capsid reduce the virion-destabilizing effect of viral RNA at acidic pH |
Q73867606 | Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation |
Q71032235 | Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages |
Q43675445 | Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells. |
Q40426196 | Origin and evolution of viruses causing classical swine fever in Cuba. |
Q44381152 | Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. |
Q39558062 | Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs |
Q40349553 | Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes |
Q35822523 | Peptides Interfering 3A Protein Dimerization Decrease FMDV Multiplication |
Q61881349 | Phenylarsine Oxide Increases Intracellular Calcium Mobility and Inhibits Ca2+-Dependent ATPase Activity in Thymocytes |
Q34428270 | Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus |
Q40158364 | Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability. |
Q43669121 | Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus |
Q40090477 | Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol |
Q40202028 | Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome |
Q34482403 | Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. |
Q34208783 | Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus |
Q56979898 | RNA immunization can protect mice against foot-and-mouth disease virus |
Q42058327 | RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice |
Q102328513 | Raccoons (Procyon lotor) in the Madrid region of Spain are carriers of antimicrobial-resistant Escherichia coli and enteropathogenic E. coli |
Q44126613 | Rational dissection of binding surfaces for mimicking of discontinuous antigenic sites. |
Q36931230 | Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection |
Q45748964 | Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs |
Q39997584 | Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. |
Q51696931 | Respiratory burst in neutrophils from asthmatic patients. |
Q50587449 | Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence. |
Q51833603 | Skewed X inactivation of the normal allele in fully mutated female carriers determines the levels of FMRP in blood and the fragile X phenotype. |
Q40778758 | Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. |
Q73699758 | Specific allergens enhance elastase release in stimulated neutrophils from asthmatic patients |
Q40673562 | Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection |
Q45029426 | Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. |
Q64973157 | Streptozotocin-induced diabetes increases fructose 2,6-bisphosphate levels and glucose metabolism in rat macrophages. |
Q40012531 | Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and vesicular stomatitis virus |
Q33359308 | Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus |
Q35895331 | Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation |
Q63248436 | Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models |
Q40682223 | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs. |
Q30588461 | The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. |
Q38900868 | The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1. |
Q39939089 | Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context |
Q56979997 | Towards a multi-site synthetic vaccine to foot-and-mouth disease: addition of discontinuous site peptide mimic increases the neutralization response in immunized animals |
Q34463399 | Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils |
Q42544381 | p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. |
Q44901263 | β-Naphthylamine induces anion superoxide production in rat peritoneal macrophages |